Antimicrobial peptides as an alternative to anti-tuberculosis drugs
Tuberculosis (TB) presently accounts for high global mortality and morbidity rates, despite the introduction four decades ago of the affordable and efficient four-drugs (isoniazid, rifampicin, pyrazinamide and ethambutol). Thus, a strong need exists for new drugs with special structures and uncommon...
Main Authors: | Almatar, Manaf, Makky, Essam A., Yakici, Gulfer, Var, Isil, Kayar, Begum, Koksal, Fatih |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018
|
Subjects: | |
Online Access: | http://umpir.ump.edu.my/id/eprint/19672/ http://umpir.ump.edu.my/id/eprint/19672/ http://umpir.ump.edu.my/id/eprint/19672/ http://umpir.ump.edu.my/id/eprint/19672/1/Antimicrobial%20peptides%20as%20an%20alternative%20to%20anti-tuberculosis%20drugs-fist-2018.pdf |
Similar Items
-
Novel Compounds Targeting InhA for TB Therapy
by: Almatar, Manaf, et al.
Published: (2018) -
Does the Development of Vaccines Advance Solutions for Tuberculosis?
by: Almatar, Manaf, et al.
Published: (2018) -
The Physiological/Pathophysiological Significance of Vitamin D in Cancer, Cardiovascular Disorders and Beyond
by: Almatar, Manaf, et al.
Published: (2017) -
Streptococcus pyogenes proteins involved in resistance to
antimicrobial peptides
by: Shahdan, Intan Azura, et al.
Published: (2010) -
Cladosporium Cladosporioides from the Perspectives of Medical and Biotechnological Approaches
by: Almatar, Manaf, et al.
Published: (2016)